BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12741443)

  • 1. Purple toes syndrome associated with warfarin therapy in a patient with antiphospholipid syndrome.
    Talmadge DB; Spyropoulos AC
    Pharmacotherapy; 2003 May; 23(5):674-7. PubMed ID: 12741443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The purple toe syndrome in female with Factor V Leiden mutation successfully treated with enoxaparin.
    Dulíček P; Bártová J; Beránek M; Malý J; Pecka M
    Clin Appl Thromb Hemost; 2013; 19(1):100-2. PubMed ID: 22531482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin-related purple toes syndrome and cholesterol microembolization.
    Hyman BT; Landas SK; Ashman RF; Schelper RL; Robinson RA
    Am J Med; 1987 Jun; 82(6):1233-7. PubMed ID: 3605140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of unilateral purple toes due to warfarin.
    Al-Niaimi F; Clark C
    Clin Exp Dermatol; 2009 Jun; 34(4):527-8. PubMed ID: 19196305
    [No Abstract]   [Full Text] [Related]  

  • 5. "Purple toes" syndrome.
    Lebsack CS; Weibert RT
    Postgrad Med; 1982 May; 71(5):81-4. PubMed ID: 7071041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late onset purple toe syndrome with warfarin successfully treated with fondaparinux.
    Rindone JP; Mellen CK; Eliason JD
    Am J Ther; 2011 Nov; 18(6):e277-9. PubMed ID: 20535004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual cutaneous reaction to anticoagulant therapy.
    Soisson AP; Vu KK; Brittain PC; Chamales I
    Mil Med; 1994 Mar; 159(3):252-3. PubMed ID: 7518893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Solitary Blue Toe: A Unique Presentation of Antiphospholipid Syndrome.
    Dimond DG; Lam JK; Wurster L; Kiser C; Driscoll K; Razzante M
    J Am Podiatr Med Assoc; 2019 May; 109(3):235-240. PubMed ID: 31268794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual side effects due to warfarin.
    Krahn MJ; Pettigrew NM; Cuddy TE
    Can J Cardiol; 1998 Jan; 14(1):90-3. PubMed ID: 9487280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: "purple toes" syndrome: an uncommon complication of oral anticoagulant therapy.
    Di Cato MA
    Postgrad Med; 1975 Dec; 58(7):133-4. PubMed ID: 1197146
    [No Abstract]   [Full Text] [Related]  

  • 11. Purple toes syndrome following stroke thrombolysis and warfarin therapy.
    Mooney T; Joseph P
    Intern Med J; 2014 Jan; 44(1):107-8. PubMed ID: 24450530
    [No Abstract]   [Full Text] [Related]  

  • 12. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
    Jørgensen M; Broholm R; Bækgaard N
    Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin initiation and monitoring with clotting factors II, VII, and X.
    Trask AS; Gosselin RC; Diaz JA; Dager WE
    Ann Pharmacother; 2004 Feb; 38(2):251-6. PubMed ID: 14742761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purple toe syndrome following anticoagulant therapy.
    Raj K; Collins B; Rangarajan S
    Br J Haematol; 2001 Sep; 114(4):740. PubMed ID: 11564060
    [No Abstract]   [Full Text] [Related]  

  • 15. Purple toe syndrome.
    Akle CA; Joiner CL
    J R Soc Med; 1981 Mar; 74(3):219. PubMed ID: 6451698
    [No Abstract]   [Full Text] [Related]  

  • 16. Atypical ischemic lower extremity ulcerations: a differential diagnosis.
    Dean SM
    Vasc Med; 2008 Feb; 13(1):47-54. PubMed ID: 18372440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis.
    Warkentin TE; Whitlock RP; Teoh KH
    Am J Hematol; 2004 Jan; 75(1):56-62. PubMed ID: 14695634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin-induced limb gangrene in the setting of lung adenocarcinoma.
    Klein L; Galvez A; Klein O; Chediak J
    Am J Hematol; 2004 Jun; 76(2):176-9. PubMed ID: 15164386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Warfarin in the treatment of antiphospholipid syndrome].
    Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
    Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
    Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
    N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.